Reduction of estimated fluid volumes following initiation of empagliflozin in patients with type 2 diabetes and cardiovascular disease: a secondary analysis of the placebo-controlled, randomized…

Overview of attention for article published in Cardiovascular Diabetology, June 2021

Altmetric Badge

Mentioned by

twitter: 1 X user

Citations

dimensions_citation: 23 Dimensions

Readers on

mendeley: 64 Mendeley

Summary X Dimensions citations

So far, Altmetric has seen 1 X post from an account with 44 followers.

Reduction of estimated fluid volumes following initiation of empagliflozin in patients with type 2 diabetes and cardiovascular disease: a secondary analysis of the placebo-controlled, randomized EMBLEM trial : https://t.co/EOcgalAsUP

29 Jun 2021

Reply Repost Favourite

This page shows the most recent X posts that mention this research output.

Click here to find out how to access more activity.